The effect of Crataegus oxycantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure

European Journal of Heart Failure

Volumn 10, Issue 6, 2008, Pages 587-593

  Zick, Suzanna M ^a,b   Gillespie, Brenda ^b   Aaronson, Keith D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Crataegus oxycantha; Crataegus Special Extract WS 1442; Hawthorn; Heart failure progression

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CRATAEGUS EXTRACT; CRATAEGUTT FORTE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; PLACEBO; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADULT; AGED; CRATAEGUS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 44649161840     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.04.008     Document Type: Article

References (23)

1. Hilfiker-Kleiner D., Landmesser U., and Drexler H. Molecular mechanisms in heart failure. J Am Coll Cardiol 48 (2006) A56-A66
2. Kuster G.M., Kotlyar E., Rude M.K., et al. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 111 (2005) 420-427
3. Weihmayr T., and Ernst E. Therapeutic effectiveness of Crataegus. Fortschr Med 114 (1996) 27-29
4. Veveris M., Koch E., and Chatterjee S.S. Crataegus Special Extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 74 (2004) 1945-1955
5. Krzeminski T., and Chatterjee S.S. Ischemia and early reperfusion induced arrhythmias: beneficial effects of an extract of Crataegus oxyacantha L. Pharm Pharmacol Lett 3 (1993) 45-48
6. Periera da Silva A., Rocha R., Silva C.M., Mira L., Duarte M.F., and Florencio M.H. Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res 14 (2000) 612-616
7. Bahorun T., Aumjaud E., Ramphul H., et al. Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. Nahrung 47 (2003) 191-198
8. Kirakosyan A., Seymour E., Kaufman P.B., Warber S., Bolling S., and Chang S.C. Antioxidant capacity of polyphenolic extracts from leaves of Crataegus laevigata and Crataegus monogyna (Hawthorn) subjected to drought and cold stress. J Agric Food Chem 51 (2003) 3973-3976
9. Zhang Z., Chang Q., Zhu M., Huang Y., Ho W.K.K., and Chen Z.Y. Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 12 (2001) 144-152
10. Chatterjee S.S., Koch E., Jaggy H., and Krzeminski T. In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms. Arzneimittelforschung 47 (1997) 821-825
11. Schwitters B. OPC in Practice (1993), Alfa Omega Edetrice, Rome
12. Masquelier J. Pycnogenols: recent advances in the therapeutical activity of procyanidins. In: Beal J.L., and Reinhard E. (Eds). Natural Products as Medicinal Agents: Plenary Lectures of the International Research Congress on Medicinal Plant Research, Strasbourg, July 1980 (1981), Hippokrates Verlag, Stuttgart
13. Pittler M.H., Schmidt K., and Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 114 (2003) 665-674
14. Aaronson K.D. HERB-CHF (Hawthorn Extract Randomized Blinded Chronic HF Study). Late-breaking and Recent Clinical Trials. 8th Annual Scientific Meeting of the Heart Failure Society of America. Toronto, Ontario, Canada. J Card Fail vol. 10 (2004) Supp (Abstract 2832)
15. Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L., Goin J.E., and Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 12 (1997) 2660-2667
16. Holubarsch C.J., Colucci W.S., Meinertz T., Gaus W., and Tendera M. Survival and prognosis: investigation of Crataegus Extract WS 1442 in congestive heart failure (SPICE)-rationale, study design and study protocol. Eur J Heart Fail 2 (2000) 431-437
17. Holubarsch C.J., WS C., Meinertz T., et al. Crataegus extract WS1442 postpones cardiac death in patients with congestive heart failure class NYHA II-III: a randomized placebo-controlled, double-blind trials in 2681 patients. Late Breaking Clinical Trials-3, Sessions 414-5 (2007), American College of Cardiology, New Orleans, LA (Abstract)
18. Johne A., Brockmoller J., Bauer S., Maurer A., Langheinrich M., and Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 66 (1999) 338-345
19. Yoo H.H., Lee M., Chung H.J., Lee S.K., and Kim D.H. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. J Agric Food Chem 55 (2007) 7620-7625
20. Lohner K., Schnabele K., Daniel H., et al. Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo. Mol Nutr Food Res 51 (2007) 293-300
21. Tankanow R., Tamer H.R., Streetman D.S., et al. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 43 (2003) 637-642
22. Liang M., Xu W., Zhang W., et al. Quantitative LC/MS/MS method and in vivo pharmacokinetic studies of vitexin rhamnoside, a bioactive constituent on cardiovascular system from hawthorn. Biomed Chromatogr 21 (2007) 422-429
23. Zuo Z., Zhang L., Zhou L., Chang Q., and Chow M. Intestinal absorption of hawthorn flavonoids-in vitro, in situ and in vivo correlations. Life Sci 79 (2006) 2455-2462